Sarcoma & Coronavirus: Your Questions Answered

Posts Tagged ‘sarcoma foundation of america’

Sarcoma & Coronavirus: Your Questions Answered

  In response to the COVID-19 outbreak, the Sarcoma Foundation of America (SFA) held a live, online session with a panel of sarcoma experts to discuss the impact the coronavirus pandemic is having on sarcoma patients and survivors.  Panelists Brian Van Tine, MD, PhD, Washington University in St. Louis, Kurt Weiss, MD, University of Pittsburgh School of Medicine, and Breelyn Wilky, MD, University of Colorado Cancer Center, answered questions submitted by the sarcoma community.  The panelists shared input on issues related to how on patients can communicate with their physicians on the risks and benefits of current care and treatment…  Read More »

Message to the Sarcoma Community

Like most of you, the Sarcoma Foundation of America (SFA) has been closely following news regarding the novel coronavirus, COVID-19.  While many questions remain regarding the impact that it will have in the United States, SFA is following recommended protocol to help stop the spread by closing our office and teleworking. SFA will continue our efforts to advocate for sarcoma patients and their families and is still available to serve as a resource to the sarcoma community.  You can reach the SFA by phone at 301-253-8687 or by email at info@curesarcoma.org. We are evaluating upcoming events and will be announcing…  Read More »

Twenty Years of the SFA

By Brandi Felser, Executive Director Twenty years later, SFA continues to be a voice and leader for the sarcoma community. Twenty years ago, before SFA, not much attention was paid to sarcoma. There were few treatment options, and no organization or institution focused on developing new therapies or expediting new treatments for patients. Sarcoma was a forgotten cancer. Fast forward 20 years. Sarcoma awareness has substantially increased, more, though not nearly enough, therapies are available, and innovative and novel agents such as immune-oncology are beginning to be applied to sarcoma. And SFA has shown that we have the ability to…  Read More »

The Power of the Sarcoma Community

By Brandi Felser, Executive Director In my very first days on the job as the new Executive Director of the Sarcoma Foundation of America, I had the opportunity to experience first-hand the power of the sarcoma community. For the first time ever, the US Food and Drug Administration (FDA) was reviewing for approval a proposed drug for the treatment of epithelioid sarcoma, a particularly rare and aggressive subtype of sarcoma. Epithelioid sarcoma has few effective treatment options and patients are often left with little or no hope for long-term survival. As a part of the approval process, the benefits of…  Read More »

Sarcoma Foundation of America Announces Brandi Felser as Executive Director

DAMASCUS, Md. – February 3, 2020 – The Sarcoma Foundation of America (SFA), an organization dedicated to increased research, awareness and advocacy for sarcoma, announces Brandi Felser as its new Executive Director.   Felser joins the SFA with more than 20 years of experience in non-profit development and management.  Felser, most recently Chief Operating Officer – Chief of Staff of the National Breast Cancer Coalition, also brings to the SFA a strong background in cancer research advocacy, making her well positioned to lead the organization’s mission to advocate for sarcoma patients by funding research and increasing awareness about this rare…  Read More »

Sarcoma Foundation of America Announces 2019 Research Grant Awards

DAMASCUS, Md. – June 27, 2019 – The Sarcoma Foundation of America (SFA), an organization dedicated to increased research and awareness for sarcoma, today announced that it has awarded three quarters of a million dollars in research funds to deserving scientists as part of its 2019 SFA Research Grant program. Fifteen research grants, each worth $50,000, have been awarded to researchers who have made it their mission to study sarcoma, a cancer that arises in the body’s soft tissue and bone. All proposals are peer reviewed by members of the SFA Medical Advisory Board who award the grants to the…  Read More »

Sarcoma Foundation of America Announces New Grant Awards for Uterine Leiomyosarcoma Research

DAMASCUS, Md. – November 1, 2018 – The Sarcoma Foundation of America (SFA), the leading organization dedicated to increased research and awareness for sarcoma, today announced two research grants awarded to projects focused on the study of uterine leiomyosarcoma.  Uterine leiomyosarcoma is a rare subtype of sarcoma, a cancer that occurs in soft tissue and bone. Made possible by the generosity of the Dr. Richard and Valerie Aronsohn Memorial Fund, these awards support investigative efforts by leading sarcoma researchers at Memorial Sloan-Kettering Cancer Center and Stanford University. These research projects are eligible for renewal, potentially bringing the SFA’s overall investment…  Read More »

Sarcoma Foundation of America Announces 2018 Research Grant Awards

DAMASCUS, Md. – May 10, 2018 – The Sarcoma Foundation of America (SFA), an organization dedicated to increased research and awareness for sarcoma, today announced that it has awarded half a million dollars in research funds to deserving scientists as part of its 2018 SFA Research Grant program.  Ten research grants, each worth $50,000, have been awarded to researchers who have made it their mission to study sarcoma, a cancer that arises in the body’s soft tissue and bone. All proposals are peer reviewed by members of the SFA Medical Advisory Board who award the grants to the best, most…  Read More »

Meet the Doctor – Kenneth Cardona, MD, FACS

Kenneth Cardona, MD, FACS, Associate Professor of Surgery, Winship Cancer Institute at Emory University Race to Cure Sarcoma™ Atlanta   What inspired you to specialize in sarcoma? The rarity and complexity of this disease in combination with our limited treatment options outside of surgical therapy inspired me to focus my advanced surgical training in surgical oncology on this unique disease. What is the focus of the research performed in your lab? I am the lead and principal investigator of the Unites States Sarcoma Collaborative, which is a multi-institutional research effort amongst 8 academic institutions across the US studying this rare…  Read More »

Sarcoma Foundation of America to Present Dr. James Wittig with the Nobility in Science Award

DAMASCUS, Md. – March 1, 2018 – The Sarcoma Foundation of America (SFA) today announced that renown orthopedic surgeon James C. Wittig, MD, is the 2018 recipient of the organization’s prestigious Nobility in Science Award. Dr. Wittig is being recognized for his contributions to sarcoma cancer research, treatment, education, and advocacy during a ceremony at the SFA’s 16th Annual fundraising event, Stand Up to Sarcoma, on Thursday, May 3, 2018, at Guastavino’s in Manhattan. The Nobility in Science Award is given to an outstanding scientist who is dedicated to the advancement of knowledge of sarcoma and works tirelessly to find new…  Read More »